Mark Ng

Mark Ng

Company: Affini-T Therapeutics

Job title: Senior Scientist, TCR Discovery

Seminars:

Transforming T-Cell Receptor Engineering & Affinity Maturation to Enhance Specificity & Efficacy While Guaranteeing Safety 1:01 pm

TCR molecules are now being engineered and optimized to increase their efficacy through affinity maturation and modifications. However, it is vital to strike the perfect balance between affinity and specificity to ensure maximum efficacy with minimal cross-reactivity. Discuss the benefits of modified TCRs compared to natural molecules, and best practice to safely improve TCR efficacy.…Read more

day: Workshop B

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.